The revenue in a weight-loss program is not the first visit. It is every visit after.

A single-center study of 2,306 patients prescribed a GLP-1 receptor agonist at a multidisciplinary academic weight-loss clinic, published in Diabetes, Obesity and Metabolism in 2025, reported medication discontinuation of 14% at three months, 24% at six months, 35% at nine months, and 50% at twelve months.

That was a clinic where the medication came at no cost to the patient. Cost is a real driver of discontinuation, so a cash-pay programme should expect its own curve to be steeper, not shallower. Real-world analyses across insured US populations have reported first-year discontinuation above 50%, and in some non-diabetes cohorts well above it.

The shape of the curve is the actionable part. Attrition is not a cliff at the end of the year, it is a steady bleed that is already at 14% by month three. By the time a quarterly review notices a patient has gone quiet, they have usually been gone for weeks.

Weight-loss programmes are subscription-shaped. The revenue is the sequence of follow-ups, refills, and check-ins, not the intake visit. A patient who completes the intake and then misses their month-three follow-up has consumed the most expensive part of your delivery and paid for the least profitable part of it.

So the retention question is narrower than it looks. You do not need to keep every patient for twelve months. You need to catch the specific patients who are between visits and drifting, in the four to six weeks before they stop refilling, which is a much smaller and much more tractable list.

That list is exactly what patient reactivation works: patients who are past their expected cadence and have not rebooked, contacted before they become a former patient rather than after.

Patients stop GLP-1 therapy for reasons a clinic can often address: gastrointestinal side effects during titration, cost and coverage changes, plateaus that feel like failure, and supply gaps. Nearly all of those are solvable if someone hears about them.

None of them reach you if the only touchpoint is a booking reminder. A patient who quietly stopped because the nausea was intolerable in week six is not going to volunteer that to a text message asking them to confirm an appointment. They will simply not book.

That is why the outreach has to ask an open question about how the patient is doing rather than pitching the next appointment, and why the answer has to be routed to a clinician when it is clinical. The call earns its keep by surfacing the reason, not by filling the slot.

Weight-loss and metabolic-health clinics skew virtual-first and modern, which shows in the software. Healthie is very common in nutrition-led and telehealth programmes, Akute Health and Cerbo appear in direct-care and concierge practices, and Medplum turns up where the clinic has built its own patient application.

All four are native Recupra integrations. Healthie is the deepest of them, and the only one where a cancellation reaches us by webhook within seconds. The integrations page lists what each one can read and write.